The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2017;10(4): 4‑12

Read: 534 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2017;10(4):4‑12. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1:263.
  2. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503—1516.
  3. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 2013;174:232—240.
  4. Frequency, predictors, and consequences of crossing over to revascularization within12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes 2013;6:409—418.
  5. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2014;46: 517—592.
  6. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008;359:677—687.
  7. Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med 2010;152:370—379.
  8. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 1992; 236:10—16.
  9. Concept of true and perceived placebo effects. BMJ 1995;311:551—553.
  10. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014;371:1208—1217.
  11. Do medical devices have enhanced placebo effects? J Clin Epidemiol 2000;53:786—792.
  12. Informed decision making for percutaneous coronary intervention for stable coronary disease. JAMA Intern Med 2015;175:1199—1206.
  13. General practice consultations: is there any point in being positive? Br Med J (Clin Res Ed) 1987;294:1200—1202.
  14. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408—412.
  15. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis. JAMA Intern Med 2014;174:1614—1621.
  16. Use of placebo controls in the evaluation of surgery: systematic review. BMJ 2014;348:g3253.
  17. Management of percutaneous coronary intervention complications. Curr Treat Options Cardiovasc Med 2017;19:25.
  18. for the Ivabradine Investigators Group. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003;107:817—823.
  19. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 2004;43:1375—1382.
  20. in collaboration with the Network for Evidence-Based Practice in Northern and Yorkshire. The UK version of the Seattle Angina Questionnaire (SAQ-UK): reliability, validity and responsiveness. J Clin Epidemiol 2001;54: 907—915.
  21. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2017; published online Aug 22. https://doi.org/10.1002/hec.3564.
  22. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987;106:793—800.
  23. . Assessment of blinding in clinical trials. Control Clin Trials 2004;25:143—156.
  24. Removing the hype from hypertension. BMJ 2014;348:g1937.
  25. NICE. Stable angina: management. NICE Clinical Guidance CG126. London: National Institute for Health and Care Excellence, 2016.
  26. 2012 ACCF/AHA/ACP/AATS/ PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44—164.
  27. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991—1001.
  28. . Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213—224.
  29. ACC/AATS/AHA/ASE/ ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 69:2212—2241.
  30. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006;48:1319—1325.
  31. Anaerobic threshold and maximal oxygen uptake in patients with coronary artery disease and stable angina before and after percutaneous transluminal coronary angioplasty. Cardiology 2002;98:127—131.
  32. Relationship of serum cardiac markers following successful percutaneous coronary intervention and subsequent exercise capacity in patients with chronic stable angina: a pilot study. Cardiology 2005;103:63—67.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.